Selective targeting of homologous DNA recombination repair by gemcitabine

International Journal of Radiation Oncology Biology Physics

Volumn 57, Issue 2, 2003, Pages 553-562

  Wachters, Floris M ^a   Van Putten, John W G ^a   Maring, Jan G ^b   Zdzienicka, Malgorzata Z ^c,d   Groen, Harry J M ^a   Kampinga, Harm H ^e  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b Diaconessenhuis Meppel   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^e UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

Double strand break repair; Homologous recombination; Rad51

Indexed keywords

CELLS; DNA; RADIOTHERAPY;

RADIOSENSITIZATION;

ONCOLOGY;

GEMCITABINE; MITOMYCIN C; RAD51 PROTEIN; RADIOSENSITIZING AGENT;

ANIMAL CELL; ARTICLE; CELL LINE; CELL MUTANT; CONTROLLED STUDY; CYTOTOXICITY; DNA STRAND BREAKAGE; DRUG EFFECT; EXCISION REPAIR; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; IRRADIATION; NONHUMAN; PRIORITY JOURNAL; RADIOSENSITIZATION;

EID: 0041881891     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(03)00503-0     Document Type: Article

References (37)

1. Shewach D.S., Hahn T.M., Chang E., et al. Metabolism of 2′,2′-difluoro-2′-deoxycytidine and radiation sensitization of human colon carcinoma cells. Cancer Res. 54:1994;3218-3223.
2. Lawrence T.S., Chang E.Y., Hahn T.M., et al. Radiosensitization of pancreatic cancer cells by 2′,2′-difluoro-2′-deoxycytidine. Int J Radiat Oncol Biol Phys. 34:1996;867-872.
3. Joschko M.A., Webster L.K., Groves J., et al. Enhancement of radiation-induced regrowth delay by gemcitabine in a human tumor xenograft model. Radiat Oncol Investig. 5:1997;62-71.
4. Milas L., Fujii T., Hunter N., et al. Enhancement of tumor radioresponse in vivo by gemcitabine. Cancer Res. 59:1999;107-114.
5. Gregoire V., Hittelman W.N., Rosier J.F., et al. Chemo-radiotherapy Radiosensitizing nucleoside analogues (review) . Oncol Rep. 6:1999;949-957.
6. Zdzienicka M.Z. Molecular processes and radiosensitivity. Strahlenther Onkol. 173:1997;457-461.
7. Van Putten J.W.G., Groen H.J.M., Smid K., et al. End-joining deficiency and radiosensitization induced by gemcitabine. Cancer Res. 61:2001;1585-1591.
8. Shewach D.S., Lawrence T.S. Radiosensitization of human tumor cells by gemcitabine in vitro. Semin Oncol. 22:1995;68-71.
9. Yang L.Y., Li L., Jiang H., et al. Expression of ERCC1 antisense RNA abrogates gemcitabine-mediated cytotoxic synergism with cisplatin in human colon tumor cells defective in mismatch repair but proficient in nucleotide excision repair. Clin Cancer Res. 6:2000;773-781.
10. Asaad N.A., Zeng Z.C., Guan J., et al. Homologous recombination as a potential target for caffeine radiosensitization in mammalian cells Reduced caffeine radiosensitization in XRCC2 and XRCC3 mutants . Oncogene. 19:2000;5788-5800.
11. Cui X., Brenneman M., Meyne J., et al. The XRCC2 and XRCC3 repair genes are required for chromosome stability in mammalian cells. Mutat Res. 434:1999;75-88.
12. Liu N., Lamerdin J.E., Tebbs R.S., et al. XRCC2 and XRCC3, new human Rad51-family members, promote chromosome stability and protect against DNA cross-links and other damages. Mol Cell. 1:1998;783-793.
13. Jones N.J., Cox R., Thacker J. Isolation and cross-sensitivity of X-ray-sensitive mutants of V79-4 hamster cells. Mutat Res. 183:1987;279-286.
14. Cartwright R., Tambini C.E., Simpson P.J., et al. The XRCC2 DNA repair gene from human and mouse encodes a novel member of the recA/RAD51 family. Nucleic Acids Res. 26:1998;3084-3089.
15. Tambini C.E., George A.M., Rommens J.M., et al. The XRCC2 DNA repair gene Identification of a positional candidate . Genomics. 41:1997;84-92.
16. Johnson R.D., Liu N., Jasin M. Mammalian XRCC2 promotes the repair of DNA double-strand breaks by homologous recombination. Nature. 401:1999;397-399.
17. Fuller L.F., Painter R.B. A Chinese hamster ovary cell line hypersensitive to ionizing radiation and deficient in repair replication. Mutat Res. 193:1988;109-121.
18. Pierce A.J., Johnson R.D., Thompson L.H., et al. XRCC3 promotes homology-directed repair of DNA damage in mammalian cells. Genes Dev. 13:1999;2633-2638.
19. Kooistra R., Pastink A., Zonneveld J.B., et al. The Drosophila melanogaster DmRAD54 gene plays a crucial role in double-strand break repair after P-element excision and acts synergistically with Ku70 in the repair of X-ray damage. Mol Cell Biol. 19:1999;6269-6275.
20. Essers J., Hendriks R.W., Swagemakers S.M., et al. Disruption of mouse RAD54 reduces ionizing radiation resistance and homologous recombination. Cell. 89:1997;195-204.
21. Essers J., Van Steeg H., De Wit J., et al. Homologous and non-homologous recombination differentially affect DNA damage repair in mice. EMBO J. 19:2000;1703-1710.
22. Wallace S.S. DNA damages processed by base excision repair Biological consequences . Int J Radiat Biol. 66:1994;579-589.
23. Wallace S.S. Enzymatic processing of radiation-induced free radical damage in DNA. Radiat Res. 150:1998;S60-S79.
24. Zdzienicka M.Z., Van der Schans G.P., Natarajan A.T., et al. A Chinese hamster ovary cell mutant (EM-C11) with sensitivity to simple alkylating agents and a very high level of sister chromatid exchanges. Mutagenesis. 7:1992;265-269.
25. Cappelli E., Taylor R., Cevasco M., et al. Involvement of XRCC1 and DNA ligase III gene products in DNA base excision repair. J Biol Chem. 272:1997;23970-23975.
26. Raderschall E., Golub E.I., Haaf T. Nuclear foci of mammalian recombination proteins are located at single-stranded DNA regions formed after DNA damage. Proc Natl Acad Sci USA. 96:1999;1921-1926.
27. Heinemann V., Hertel L.W., Grindey G.B., et al. Comparison of the cellular pharmacokinetics and toxicity of 2′,2′-difluorodeoxycytidine and 1-beta-D-arabinofuranosylcytosine. Cancer Res. 48:1988;4024-4031.
28. De Silva I.U., McHugh P.J., Clingen P.H., et al. Defining the roles of nucleotide excision repair and recombination in the repair of DNA interstrand cross-links in mammalian cells. Mol Cell Biol. 20:2000;7980-7990.
29. O'Regan P., Wilson C., Townsend S., et al. XRCC2 is a nuclear RAD51-like protein required for damage-dependent RAD51 focus formation without the need for ATP binding. J Biol Chem. 276:2001;22148-22153.
30. Kampinga H.H., Dikomey E. Hyperthermic radiosensitization Mode of action and clinical relevance . Int J Radiat Biol. 77:2001;399-408.
31. Tashiro S., Walter J., Shinohara A., et al. Rad51 accumulation at sites of DNA damage and in postreplicative chromatin. J Cell Biol. 150:2000;283-291.
32. Wang Z.M., Chen Z.P., Xu Z.Y., et al. In vitro evidence for homologous recombinational repair in resistance to melphalan. J Natl Cancer Inst. 93:2001;1473-1478.
33. Haaf T., Golub E.I., Reddy G., et al. Nuclear foci of mammalian Rad51 recombination protein in somatic cells after DNA damage and its localization in synaptonemal complexes. Proc Natl Acad Sci USA. 92:1995;2298-2302.
34. Hoeijmakers J.H. Genome maintenance mechanisms for preventing cancer. Nature. 411:2001;366-374.
35. Latz D., Fleckenstein K., Eble M., et al. Radiosensitizing potential of gemcitabine (2′,2′-difluoro-2′-deoxycytidine) within the cell cycle in vitro. Int J Radiat Oncol Biol Phys. 41:1998;875-882.
36. Takata M., Sasaki M.S., Sonoda E., et al. Homologous recombination and non-homologous end-joining pathways of DNA double-strand break repair have overlapping roles in the maintenance of chromosomal integrity in vertebrate cells. EMBO J. 17:1998;5497-5508.
37. Essers J., Houtsmuller A.B., Van Veelen L., et al. Nuclear dynamics of RAD52 group homologous recombination proteins in response to DNA damage. EMBO J. 21:2002;2030-2037.